Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

435 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-10-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is to prospectively evaluate whether performing an intra-uterine insemination 24 hours after the spontaneous LH peak may result in significantly higher ongoing pregnancy rates compared to 48 hours.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Evaluating the Timing of Intrauterine Insemination in Relation to Positive Home Ovulation Prediction Kit

NCT02294773

Infertility

COMPLETED NA

Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination

NCT06804538

Infertility Intrauterine Insemination (IUI)

RECRUITING NA

HCG Versus Spontaneous LH in Intrauterine Insemination (IUI ) Cycles

NCT01414673

Spontaneous Triggering of Ovulation vs. Administration of Human Chorionic Gonadotropin in Patients Undergoing IUI

COMPLETED EARLY_PHASE1

Does Hormonal Luteal Support After Intra-uterine Insemination (IUI) Increase the Pregnancy Rate?

NCT00700492

Subfertility

TERMINATED NA

36 Versus 42 Hour Time Interval From Ovulation to Intrauterine Insemination

NCT02210611

Infertility

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

intrauterine insemination after 24 hours

Group Type EXPERIMENTAL

intra-uterine insemination

Intervention Type PROCEDURE

Artificial insemination is the process by which sperm is placed into the reproductive tract of a female for the purpose of impregnating the female by using means other than sexual intercourse or natural insemination.

Control group

intrauterine insemination after 48 hours

Group Type ACTIVE_COMPARATOR

intra-uterine insemination

Intervention Type PROCEDURE

Artificial insemination is the process by which sperm is placed into the reproductive tract of a female for the purpose of impregnating the female by using means other than sexual intercourse or natural insemination.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intra-uterine insemination

Artificial insemination is the process by which sperm is placed into the reproductive tract of a female for the purpose of impregnating the female by using means other than sexual intercourse or natural insemination.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

no other interventions

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* below 39 years of age on the day of LH peak
* donor semen
* natural cycle (without CC)
* cycle with less than 3 follicles reaching 15 mm of diameter or more.
* with basal hormonal values of progesterone ( \< 1,2 ng/dl)